Revolutionizing antiviral therapy: harnessing nanotechnology to unlock the power of phytoconstituents

The convergence of phytotherapy and nanotechnology represents a promising frontier in antiviral drug development. While significant progress has been made in identifying active phytochemicals and formulating them with nanocarriers, more <i>in-vivo</i> data, clinical research, standardization efforts, and regulatory clarity are needed. This review may serve as a foundational resource for researchers aiming to develop innovative antiviral therapies based on natural compounds and nanotechnology-based delivery systems.